 Ding Xue
Concepts (298)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Caenorhabditis elegans | 38 | 2024 | 296 | 9.620 |
Why?
| | Caenorhabditis elegans Proteins | 35 | 2024 | 194 | 8.980 |
Why?
| | Apoptosis | 32 | 2022 | 2489 | 3.790 |
Why?
| | Caspases | 21 | 2017 | 245 | 3.660 |
Why?
| | Mitochondria | 11 | 2024 | 875 | 2.130 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 9 | 2016 | 232 | 1.980 |
Why?
| | Phosphatidylserines | 5 | 2013 | 88 | 1.380 |
Why?
| | Endodeoxyribonucleases | 6 | 2016 | 67 | 1.280 |
Why?
| | Phospholipid Transfer Proteins | 3 | 2019 | 10 | 1.200 |
Why?
| | Mitochondrial Proteins | 6 | 2016 | 247 | 1.160 |
Why?
| | Membrane Proteins | 9 | 2015 | 1119 | 1.120 |
Why?
| | Proto-Oncogene Proteins c-akt | 4 | 2019 | 434 | 1.080 |
Why?
| | Repressor Proteins | 6 | 2016 | 404 | 1.020 |
Why?
| | Carcinoma, Renal Cell | 4 | 2022 | 178 | 1.010 |
Why?
| | DNA Fragmentation | 4 | 2016 | 42 | 0.920 |
Why?
| | Deoxyribonucleases | 4 | 2010 | 23 | 0.880 |
Why?
| | Kidney Neoplasms | 4 | 2022 | 347 | 0.880 |
Why?
| | Amino Acid Sequence | 17 | 2015 | 2057 | 0.820 |
Why?
| | Animals | 45 | 2024 | 35404 | 0.790 |
Why?
| | Amino Acid Motifs | 4 | 2019 | 215 | 0.790 |
Why?
| | Intracellular Space | 2 | 2012 | 69 | 0.780 |
Why?
| | DNA, Helminth | 6 | 2010 | 18 | 0.780 |
Why?
| | Germ Cells | 4 | 2015 | 60 | 0.760 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2023 | 190 | 0.760 |
Why?
| | DNA, Mitochondrial | 3 | 2023 | 190 | 0.740 |
Why?
| | Molecular Sequence Data | 16 | 2015 | 2833 | 0.700 |
Why?
| | Calcium-Binding Proteins | 3 | 2016 | 213 | 0.680 |
Why?
| | Animals, Genetically Modified | 8 | 2019 | 231 | 0.670 |
Why?
| | Trans-Activators | 2 | 2012 | 392 | 0.660 |
Why?
| | Signal Transduction | 14 | 2023 | 4935 | 0.660 |
Why?
| | Sex Determination Processes | 2 | 2010 | 7 | 0.650 |
Why?
| | Carrier Proteins | 3 | 2021 | 741 | 0.580 |
Why?
| | Receptors, Cell Surface | 2 | 2015 | 381 | 0.580 |
Why?
| | Cadherins | 1 | 2019 | 190 | 0.580 |
Why?
| | GTPase-Activating Proteins | 2 | 2015 | 81 | 0.560 |
Why?
| | Mutation | 14 | 2023 | 3705 | 0.560 |
Why?
| | Caspase Inhibitors | 4 | 2017 | 81 | 0.550 |
Why?
| | Cognition | 1 | 2024 | 1124 | 0.530 |
Why?
| | Embryo, Nonmammalian | 7 | 2016 | 167 | 0.520 |
Why?
| | Calcium | 2 | 2012 | 1212 | 0.510 |
Why?
| | Fertilization | 1 | 2016 | 42 | 0.510 |
Why?
| | Intestines | 1 | 2019 | 349 | 0.490 |
Why?
| | RNA Interference | 7 | 2019 | 450 | 0.490 |
Why?
| | MicroRNAs | 2 | 2019 | 680 | 0.480 |
Why?
| | DNA | 4 | 2009 | 1406 | 0.470 |
Why?
| | Apoptosis Regulatory Proteins | 4 | 2015 | 182 | 0.440 |
Why?
| | Molecular Biology | 1 | 2014 | 57 | 0.420 |
Why?
| | Caspase 3 | 1 | 2014 | 244 | 0.400 |
Why?
| | Models, Molecular | 3 | 2021 | 1488 | 0.400 |
Why?
| | Microscopy, Immunoelectron | 1 | 2012 | 42 | 0.390 |
Why?
| | Phagocytosis | 4 | 2013 | 362 | 0.390 |
Why?
| | Embryonic Development | 3 | 2024 | 113 | 0.370 |
Why?
| | Protein Binding | 8 | 2021 | 2122 | 0.370 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2012 | 133 | 0.370 |
Why?
| | Adenosine Triphosphate | 2 | 2024 | 481 | 0.370 |
Why?
| | Hepatocytes | 1 | 2012 | 215 | 0.370 |
Why?
| | Proto-Oncogene Proteins | 3 | 2021 | 634 | 0.360 |
Why?
| | Lysosomes | 1 | 2011 | 137 | 0.360 |
Why?
| | Cell Membrane | 3 | 2013 | 734 | 0.350 |
Why?
| | Intracellular Membranes | 2 | 2015 | 83 | 0.350 |
Why?
| | Ribonuclease III | 1 | 2010 | 37 | 0.330 |
Why?
| | Virus Replication | 1 | 2012 | 453 | 0.330 |
Why?
| | Caspase 2 | 1 | 2009 | 13 | 0.320 |
Why?
| | Sequence Homology, Amino Acid | 6 | 2015 | 371 | 0.310 |
Why?
| | Cysteine Endopeptidases | 3 | 2004 | 68 | 0.300 |
Why?
| | SKP Cullin F-Box Protein Ligases | 1 | 2008 | 8 | 0.300 |
Why?
| | Gene Expression Regulation, Developmental | 4 | 2016 | 820 | 0.300 |
Why?
| | Protein Biosynthesis | 1 | 2010 | 406 | 0.290 |
Why?
| | Receptors, Notch | 1 | 2008 | 84 | 0.280 |
Why?
| | Multienzyme Complexes | 2 | 2006 | 68 | 0.280 |
Why?
| | Protein Transport | 3 | 2021 | 429 | 0.280 |
Why?
| | Cloning, Molecular | 4 | 2015 | 524 | 0.280 |
Why?
| | RNA-Binding Proteins | 1 | 2010 | 388 | 0.270 |
Why?
| | Base Sequence | 5 | 2015 | 2142 | 0.270 |
Why?
| | Toluene | 1 | 2006 | 11 | 0.270 |
Why?
| | Genome | 3 | 2014 | 278 | 0.270 |
Why?
| | Benzene | 1 | 2006 | 15 | 0.270 |
Why?
| | Cobalt | 1 | 2007 | 50 | 0.270 |
Why?
| | Gene Expression Regulation, Neoplastic | 4 | 2021 | 1327 | 0.260 |
Why?
| | Green Fluorescent Proteins | 3 | 2015 | 390 | 0.260 |
Why?
| | Cell Death | 3 | 2015 | 352 | 0.260 |
Why?
| | Helminth Proteins | 3 | 2001 | 23 | 0.260 |
Why?
| | Chlorobenzenes | 1 | 2006 | 9 | 0.260 |
Why?
| | Biphenyl Compounds | 1 | 2006 | 60 | 0.260 |
Why?
| | SELEX Aptamer Technique | 1 | 2006 | 14 | 0.250 |
Why?
| | Naphthalenes | 1 | 2006 | 57 | 0.250 |
Why?
| | Structure-Activity Relationship | 3 | 2021 | 547 | 0.240 |
Why?
| | Cytosol | 3 | 2012 | 219 | 0.240 |
Why?
| | Aptamers, Nucleotide | 1 | 2006 | 77 | 0.240 |
Why?
| | Enzyme Activation | 4 | 2015 | 812 | 0.230 |
Why?
| | Cell Cycle Proteins | 1 | 2008 | 583 | 0.230 |
Why?
| | Sexual Behavior, Animal | 1 | 2024 | 52 | 0.220 |
Why?
| | Homeodomain Proteins | 1 | 2007 | 493 | 0.220 |
Why?
| | Permeability | 2 | 2015 | 158 | 0.220 |
Why?
| | Embryo Loss | 1 | 2023 | 4 | 0.220 |
Why?
| | Cell Line, Tumor | 6 | 2022 | 3184 | 0.210 |
Why?
| | Forkhead Transcription Factors | 1 | 2024 | 184 | 0.210 |
Why?
| | Recombinant Fusion Proteins | 4 | 2010 | 650 | 0.210 |
Why?
| | Nuclear Proteins | 1 | 2008 | 660 | 0.210 |
Why?
| | Models, Biological | 4 | 2019 | 1724 | 0.210 |
Why?
| | Cytoskeletal Proteins | 1 | 2003 | 147 | 0.210 |
Why?
| | Viral Regulatory and Accessory Proteins | 2 | 2012 | 27 | 0.200 |
Why?
| | Reproduction | 1 | 2024 | 198 | 0.200 |
Why?
| | TNF Receptor-Associated Factor 1 | 1 | 2022 | 8 | 0.200 |
Why?
| | Sequence Alignment | 3 | 2009 | 331 | 0.190 |
Why?
| | Autophagy | 2 | 2016 | 266 | 0.190 |
Why?
| | Methyltransferases | 1 | 2022 | 70 | 0.180 |
Why?
| | Gene Expression Regulation | 2 | 2015 | 2545 | 0.180 |
Why?
| | Nuclear Receptor Subfamily 2, Group C, Member 2 | 1 | 2021 | 1 | 0.180 |
Why?
| | Pro-Opiomelanocortin | 1 | 2021 | 17 | 0.180 |
Why?
| | Neurodegenerative Diseases | 1 | 2023 | 114 | 0.180 |
Why?
| | In Situ Nick-End Labeling | 3 | 2010 | 123 | 0.180 |
Why?
| | Behavior, Animal | 1 | 2024 | 496 | 0.180 |
Why?
| | Binding Sites | 3 | 2021 | 1251 | 0.180 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2003 | 399 | 0.180 |
Why?
| | Proteasome Endopeptidase Complex | 2 | 2016 | 149 | 0.170 |
Why?
| | Adenosine | 1 | 2022 | 227 | 0.170 |
Why?
| | Phagocytes | 2 | 2012 | 97 | 0.170 |
Why?
| | Annexin A5 | 2 | 2012 | 23 | 0.170 |
Why?
| | Transcription Factors | 1 | 2007 | 1645 | 0.160 |
Why?
| | Nomograms | 1 | 2019 | 47 | 0.160 |
Why?
| | Cell Survival | 4 | 2017 | 1086 | 0.160 |
Why?
| | DNA Primers | 2 | 2015 | 508 | 0.160 |
Why?
| | Neoplasm Grading | 1 | 2019 | 283 | 0.150 |
Why?
| | Ubiquitin | 2 | 2011 | 63 | 0.150 |
Why?
| | Receptors, Thyroid Hormone | 1 | 2018 | 21 | 0.150 |
Why?
| | Gene Expression Profiling | 3 | 2021 | 1686 | 0.140 |
Why?
| | Endocytosis | 1 | 2019 | 162 | 0.140 |
Why?
| | Seminoma | 1 | 2018 | 18 | 0.140 |
Why?
| | Receptors, Steroid | 1 | 2018 | 49 | 0.140 |
Why?
| | Parkinson Disease | 1 | 2023 | 462 | 0.140 |
Why?
| | Testicular Neoplasms | 1 | 2018 | 102 | 0.130 |
Why?
| | Phenotype | 3 | 2019 | 3062 | 0.130 |
Why?
| | Mitochondrial Membranes | 1 | 2016 | 38 | 0.130 |
Why?
| | Protein Conformation | 1 | 2019 | 861 | 0.130 |
Why?
| | DNA Damage | 2 | 2009 | 383 | 0.120 |
Why?
| | Spermatozoa | 1 | 2016 | 91 | 0.120 |
Why?
| | Sequence Homology, Nucleic Acid | 2 | 2007 | 151 | 0.120 |
Why?
| | Dynamins | 1 | 2015 | 35 | 0.120 |
Why?
| | Humans | 18 | 2023 | 129687 | 0.120 |
Why?
| | Male | 9 | 2024 | 63691 | 0.120 |
Why?
| | Molecular Structure | 2 | 2006 | 483 | 0.120 |
Why?
| | Cell Movement | 1 | 2019 | 950 | 0.120 |
Why?
| | Time-Lapse Imaging | 1 | 2015 | 20 | 0.120 |
Why?
| | Cell Nucleus | 3 | 2003 | 590 | 0.110 |
Why?
| | Phosphatidylinositol Phosphates | 1 | 2014 | 39 | 0.110 |
Why?
| | Immunoprecipitation | 1 | 2015 | 156 | 0.110 |
Why?
| | Pharynx | 2 | 2008 | 58 | 0.110 |
Why?
| | Computational Biology | 1 | 2019 | 594 | 0.110 |
Why?
| | Fluorescence | 1 | 2015 | 156 | 0.110 |
Why?
| | Gene Regulatory Networks | 1 | 2016 | 280 | 0.110 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 338 | 0.110 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2019 | 956 | 0.110 |
Why?
| | Mammals | 1 | 2015 | 274 | 0.110 |
Why?
| | Transcriptome | 1 | 2019 | 875 | 0.110 |
Why?
| | Biomarkers, Tumor | 1 | 2019 | 1161 | 0.100 |
Why?
| | Genes, Suppressor | 1 | 2012 | 5 | 0.100 |
Why?
| | bcl-X Protein | 1 | 2012 | 42 | 0.100 |
Why?
| | Oxidation-Reduction | 2 | 2007 | 1031 | 0.100 |
Why?
| | Hep G2 Cells | 1 | 2012 | 61 | 0.100 |
Why?
| | Hepatitis B virus | 1 | 2012 | 36 | 0.100 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2014 | 362 | 0.100 |
Why?
| | Lipids | 2 | 2015 | 628 | 0.100 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 836 | 0.100 |
Why?
| | Female | 6 | 2024 | 68751 | 0.100 |
Why?
| | Heat-Shock Proteins | 1 | 2013 | 136 | 0.100 |
Why?
| | Blotting, Western | 1 | 2015 | 1204 | 0.100 |
Why?
| | Ultraviolet Rays | 1 | 2015 | 383 | 0.100 |
Why?
| | Polymerase Chain Reaction | 1 | 2015 | 1033 | 0.090 |
Why?
| | Sequence Analysis, DNA | 1 | 2015 | 778 | 0.090 |
Why?
| | Necrosis | 1 | 2012 | 232 | 0.090 |
Why?
| | Protein Structure, Tertiary | 2 | 2015 | 844 | 0.090 |
Why?
| | Time Factors | 3 | 2014 | 6545 | 0.090 |
Why?
| | Biosensing Techniques | 1 | 2012 | 118 | 0.090 |
Why?
| | Pregnancy | 1 | 2023 | 6412 | 0.090 |
Why?
| | RNA, Helminth | 1 | 2010 | 17 | 0.080 |
Why?
| | 3' Untranslated Regions | 1 | 2010 | 138 | 0.080 |
Why?
| | RNA, Double-Stranded | 1 | 2010 | 47 | 0.080 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2011 | 216 | 0.080 |
Why?
| | Alleles | 1 | 2013 | 843 | 0.080 |
Why?
| | Mice, Inbred BALB C | 1 | 2012 | 1248 | 0.080 |
Why?
| | RNA, Small Interfering | 2 | 2021 | 590 | 0.080 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2012 | 443 | 0.080 |
Why?
| | Neurons | 2 | 2008 | 1509 | 0.080 |
Why?
| | Genes, bcl-2 | 1 | 2009 | 21 | 0.080 |
Why?
| | Catalytic Domain | 1 | 2010 | 218 | 0.080 |
Why?
| | Ubiquitin-Protein Ligase Complexes | 1 | 2008 | 7 | 0.080 |
Why?
| | Cullin Proteins | 1 | 2008 | 13 | 0.080 |
Why?
| | Recombinant Proteins | 2 | 2003 | 1310 | 0.070 |
Why?
| | Microscopy, Electron | 1 | 2009 | 425 | 0.070 |
Why?
| | POU Domain Factors | 1 | 2007 | 5 | 0.070 |
Why?
| | Dimerization | 1 | 2008 | 193 | 0.070 |
Why?
| | Muscle Cells | 1 | 2008 | 43 | 0.070 |
Why?
| | Genes, Helminth | 1 | 2007 | 26 | 0.070 |
Why?
| | Conserved Sequence | 1 | 2008 | 227 | 0.070 |
Why?
| | X Chromosome | 1 | 2007 | 50 | 0.070 |
Why?
| | Protein Subunits | 1 | 2008 | 233 | 0.070 |
Why?
| | Peptides | 1 | 2012 | 926 | 0.070 |
Why?
| | Benzene Derivatives | 1 | 2006 | 9 | 0.070 |
Why?
| | Cyclohexanes | 1 | 2006 | 21 | 0.070 |
Why?
| | Electrochemistry | 1 | 2007 | 79 | 0.070 |
Why?
| | Staining and Labeling | 1 | 2007 | 143 | 0.070 |
Why?
| | Nucleic Acid Hybridization | 1 | 2007 | 188 | 0.070 |
Why?
| | Larva | 2 | 2014 | 215 | 0.070 |
Why?
| | Mutation, Missense | 1 | 2008 | 316 | 0.060 |
Why?
| | Benzoquinones | 1 | 2006 | 48 | 0.060 |
Why?
| | Oils | 1 | 2006 | 21 | 0.060 |
Why?
| | Carcinogens | 1 | 2006 | 109 | 0.060 |
Why?
| | Growth and Development | 1 | 2006 | 6 | 0.060 |
Why?
| | Cell Count | 1 | 2006 | 318 | 0.060 |
Why?
| | Kinetics | 1 | 2009 | 1645 | 0.060 |
Why?
| | Catalysis | 1 | 2007 | 312 | 0.060 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2006 | 140 | 0.060 |
Why?
| | Biological Transport | 1 | 2007 | 405 | 0.060 |
Why?
| | Down-Regulation | 2 | 2021 | 631 | 0.060 |
Why?
| | Cell Proliferation | 2 | 2018 | 2378 | 0.060 |
Why?
| | Protein Structure, Secondary | 1 | 2006 | 342 | 0.060 |
Why?
| | Mice | 3 | 2021 | 16982 | 0.060 |
Why?
| | Intestinal Mucosa | 1 | 2009 | 593 | 0.060 |
Why?
| | In Vitro Techniques | 1 | 2006 | 1090 | 0.060 |
Why?
| | Membrane Potentials | 1 | 2004 | 291 | 0.050 |
Why?
| | rac GTP-Binding Proteins | 1 | 2003 | 32 | 0.050 |
Why?
| | Aged, 80 and over | 3 | 2021 | 7064 | 0.050 |
Why?
| | Peptide Hydrolases | 1 | 2004 | 108 | 0.050 |
Why?
| | Pyridines | 1 | 2007 | 478 | 0.050 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 1 | 2003 | 60 | 0.050 |
Why?
| | Apoptosis Inducing Factor | 1 | 2002 | 4 | 0.050 |
Why?
| | Flavoproteins | 1 | 2002 | 8 | 0.050 |
Why?
| | Hydrolysis | 1 | 2003 | 186 | 0.050 |
Why?
| | Swimming | 1 | 2023 | 48 | 0.050 |
Why?
| | Acoustics | 1 | 2023 | 52 | 0.050 |
Why?
| | Sex Characteristics | 1 | 2007 | 735 | 0.050 |
Why?
| | Sex Factors | 1 | 2008 | 1973 | 0.050 |
Why?
| | Autoimmune Diseases | 1 | 2006 | 428 | 0.050 |
Why?
| | Disease Progression | 2 | 2021 | 2628 | 0.050 |
Why?
| | Genetic Complementation Test | 1 | 2001 | 64 | 0.050 |
Why?
| | Sensitivity and Specificity | 1 | 2006 | 1844 | 0.050 |
Why?
| | Aged | 4 | 2023 | 22101 | 0.050 |
Why?
| | Pituitary ACTH Hypersecretion | 1 | 2021 | 10 | 0.040 |
Why?
| | ACTH-Secreting Pituitary Adenoma | 1 | 2021 | 11 | 0.040 |
Why?
| | Mixed Function Oxygenases | 1 | 2021 | 41 | 0.040 |
Why?
| | Mutagenesis | 1 | 2001 | 179 | 0.040 |
Why?
| | Molecular Conformation | 1 | 2021 | 141 | 0.040 |
Why?
| | Angiogenesis Inhibitors | 1 | 2022 | 218 | 0.040 |
Why?
| | Alcohol Oxidoreductases | 1 | 2021 | 58 | 0.040 |
Why?
| | Prognosis | 2 | 2019 | 3772 | 0.040 |
Why?
| | Adrenocorticotropic Hormone | 1 | 2021 | 133 | 0.040 |
Why?
| | DNA-Binding Proteins | 1 | 2007 | 1441 | 0.040 |
Why?
| | Neovascularization, Pathologic | 1 | 2022 | 296 | 0.040 |
Why?
| | Neoplasms | 1 | 2015 | 2454 | 0.040 |
Why?
| | Microscopy, Interference | 1 | 2000 | 9 | 0.040 |
Why?
| | Chromosome Mapping | 1 | 2001 | 499 | 0.040 |
Why?
| | Drug Discovery | 1 | 2021 | 131 | 0.040 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2021 | 329 | 0.040 |
Why?
| | Amino Acid Substitution | 1 | 2000 | 284 | 0.040 |
Why?
| | HeLa Cells | 1 | 2001 | 611 | 0.040 |
Why?
| | Disorders of Sex Development | 1 | 2000 | 38 | 0.040 |
Why?
| | MAP Kinase Signaling System | 1 | 2021 | 314 | 0.040 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2021 | 808 | 0.040 |
Why?
| | COS Cells | 1 | 2018 | 186 | 0.040 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2022 | 752 | 0.030 |
Why?
| | Caspases, Initiator | 1 | 2017 | 17 | 0.030 |
Why?
| | Naproxen | 1 | 2017 | 17 | 0.030 |
Why?
| | Inhibitory Concentration 50 | 1 | 2017 | 86 | 0.030 |
Why?
| | Ketorolac | 1 | 2017 | 20 | 0.030 |
Why?
| | Ibuprofen | 1 | 2017 | 81 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2018 | 483 | 0.030 |
Why?
| | Small Molecule Libraries | 1 | 2017 | 86 | 0.030 |
Why?
| | Substrate Specificity | 1 | 2017 | 371 | 0.030 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2018 | 201 | 0.030 |
Why?
| | Gene Expression | 1 | 2021 | 1465 | 0.030 |
Why?
| | High-Throughput Screening Assays | 1 | 2017 | 139 | 0.030 |
Why?
| | Cells, Cultured | 1 | 2003 | 4102 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2018 | 697 | 0.030 |
Why?
| | Survival Rate | 1 | 2019 | 1872 | 0.030 |
Why?
| | RNA-Induced Silencing Complex | 1 | 2014 | 7 | 0.030 |
Why?
| | HCT116 Cells | 1 | 2015 | 76 | 0.030 |
Why?
| | Genetic Pleiotropy | 1 | 2014 | 29 | 0.030 |
Why?
| | Up-Regulation | 1 | 2018 | 836 | 0.030 |
Why?
| | Transcription, Genetic | 1 | 2021 | 1416 | 0.030 |
Why?
| | Neoplasm Staging | 1 | 2018 | 1281 | 0.030 |
Why?
| | Middle Aged | 3 | 2021 | 31165 | 0.030 |
Why?
| | Fluorouracil | 1 | 2015 | 197 | 0.030 |
Why?
| | Pluripotent Stem Cells | 1 | 2014 | 77 | 0.030 |
Why?
| | Enhancer Elements, Genetic | 1 | 2014 | 177 | 0.030 |
Why?
| | Cell Lineage | 1 | 2014 | 332 | 0.030 |
Why?
| | Myristoylated Alanine-Rich C Kinase Substrate | 1 | 2012 | 6 | 0.030 |
Why?
| | Unilamellar Liposomes | 1 | 2012 | 8 | 0.030 |
Why?
| | Adult | 3 | 2021 | 35607 | 0.030 |
Why?
| | Ligands | 1 | 2015 | 621 | 0.020 |
Why?
| | Circular Dichroism | 1 | 2012 | 147 | 0.020 |
Why?
| | Cell Line | 1 | 2017 | 2779 | 0.020 |
Why?
| | Fluorescent Dyes | 1 | 2012 | 313 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2021 | 4076 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2019 | 4892 | 0.020 |
Why?
| | Rats | 1 | 2012 | 5485 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2019 | 14525 | 0.010 |
Why?
| | Young Adult | 1 | 2018 | 12457 | 0.010 |
Why?
|
|
Xue's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|